ILLUMENATE EU Randomized Clinical Trial (EU RCT)
Prospective, Randomized, Multi-center, Single-blinded Study for the Treatment of Subjects Presenting With De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using Paclitaxel or Bare Percutaneous Transluminal Angioplasty Balloon Catheter
Sponsor: Spectranetics Corporation
A NA clinical study on Claudication and Peripheral Arterial Disease, this trial is completed. The trial is conducted by Spectranetics Corporation and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2021 — Nov 2021 [monthly]
Unknown Status NA
-
Jul 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jul 2020 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Spectranetics Corporation
For direct contact, visit the study record on ClinicalTrials.gov .